Physician profile
Marian Colosimo
NPI 1407816739
$2,364.46
in general payments reported to CMS, 2019-2025
11 companies · $650 in 2025
The $650 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $93.90 · 2021: $267 · 2022: $303 · 2023: $387 · 2024: $464 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,500.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,106.50 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $291.00 | 2021-2025 | Azstarys |
| Alk-Abello, INC | $156.70 | 2023-2025 | Odactra, Grastek, Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $147.49 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $140.69 | 2019 | |
| Merck Sharp & Dohme LLC | $124.53 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $118.54 | 2022-2025 | |
| Sanofi Pasteur INC. | $96.73 | 2019-2025 | |
| Cranial Technologies, INC | $79.73 | 2019-2025 | Doc Band |
| Adlon Therapeutics L.P. | $64.57 | 2021 | |
| Glaxosmithkline, LLC. | $37.98 | 2020-2025 | Penmenvy, Bexsero |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marian Colosimo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.